Poisoning due to class 1B antiarrhythmic drugs. Lignocaine, mexiletine and tocainide (Q38240990)

31 August 2017

1 reference

title

Poisoning due to class 1B antiarrhythmic drugs. Lignocaine, mexiletine and tocainide (English)

1 reference

31 August 2017

1 reference

C P Denaro

1

1 reference

31 August 2017

N L Benowitz

series ordinal

2

1 reference

31 August 2017

publication date

1 November 1989

1 reference

Medical toxicology and adverse drug experience

31 August 2017

published in

1 reference

31 August 2017

volume

4

1 reference

31 August 2017

issue

6

1 reference

31 August 2017

page(s)

412-428

1 reference

Lidocaine toxicity following subcutaneous administration

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03259923

Severe dermatologic reactions reported after treatment with tocainide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259923

Inadvertent massive lidocaine overdose causing temporary complete heart block in myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259923

On the role of alpha 1-acid glycoprotein in lignocaine accumulation following myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259923

A sudden death due to tocainide overdose.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259923

Influence of long-term infusions on lidocaine kinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259923

Pharmacokinetics in patients with cardiac failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259923

Clinical Pharmacokinetics of Lignocaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259923

Relation between Plasma Lignocaine Levels and Induced Haemodynamic Changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259923

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259923

Sinus Standstill Following Intravenous Lidocaine Administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259923

Lidocaine pharmacokinetics during cardiac arrest and external cardiopulmonary resuscitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259923

Torsades de pointes as a manifestation of mexiletine toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259923

Pharmacokinetics and metabolism of lidocaine in patients with renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259923

Excessive serum lidocaine levels during maintenance infusions: mechanisms and prevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259923

Electrophysiological Actions of Lidocaine on Canine Ventricular Muscle and Purkinje Fibers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259923

Plasma levels, protein binding, and elimination data of lidocaine and active metabolites in cardiac patients of various ages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259923

Intravenous lidocaine overdosage in a child.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259923

Tocainide-induced ventricular fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259923

Mexiletine in refractory ventricular arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259923

Massive Lidocaine Poisoning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259923

Reliability of antiarrhythmic drug plasma concentration monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259923

Extracorporeal pump assistance--novel treatment for acute lidocaine poisoning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259923

Effect of propranolol, procainamide, and lidocaine on ventricular automaticity and reentry in experimental myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259923

Quantitative study of the effect of lidocaine on the threshold for ventricular fibrillation in the dog.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259923

Stereoselective disposition of mexiletine in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259923

Deaths from paracervical anesthesia used for first-trimester abortion, 1972-1975

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259923

Lidocaine-induced heart block in patients with bundle branch block

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259923

Influence of congestive heart failure on blood levels of lidocaine and its active monodeethylated metabolite

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259923

Seizures secondary to oral viscous lidocaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259923

Safety evaluation of tocainide in the American Emergency Use Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259923

Adult respiratory distress syndrome following administration of lidocaine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259923

Letter: Fatal mexiletine overdose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259923

Antiarrhythmic efficacy, pharmacokinetics and clinical safety of tocainide in convalescent myocardial infarction patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259923

In vivo electrophysiological effects of lidocaine in canine acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259923

Time-dependent kinetics of lignocaine in the isolated perfused rat liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259923

Pharmacokinetics of lidocaine after prolonged intravenous infusions in uncomplicated myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259923

Atrioventricular block with lidocaine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259923

Lidocaine in the prevention of primary ventricular fibrillation. A double-blind, randomized study of 212 consecutive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259923

Mexiletine disposition: individual variation in response to urine acidification and alkalinisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259923

Massive lignocaine overdose during cardiopulmonary bypass. Successful treatment with cardiac pacing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259923

Clinical use and toxicity of intravenous lidocaine. A report from the Boston Collaborative Drug Surveillance Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259923

Impaired Lignocaine metabolism in patients with myocardial infarction and cardiac failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259923

Character of adverse effects of prophylactic lidocaine in the coronary care unit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259923

Class 1B agents lidocaine, mexiletine, tocainide, phenytoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259923

21 January 2018

Drug therapy. Tocainide

1 reference

https://api.crossref.org/works/10.1007%2FBF03259923

Electrophysiological effects of mexiletine in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259923

Increased alpha-1-acid glycoprotein and lidocaine disposition in myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259923

Efficacy of a new oral agent (tocainide) in the acute treatment of refractory ventricular arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259923

Effect on the seizure threshold in dogs of tocainide/lidocaine administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259923

Serum tocainide enantiomer concentrations in human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259923

Current concepts of the mechanism of action of local anesthetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259923

Identification of glycinexylidide in patients treated with intravenous lidocaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259923

Pharmacological activity, metabolism, and pharmacokinetics of glycinexylidide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259923

Effects of propranolol and pindolol on plasma lignocaine clearance in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259923

The pharmacokinetics and pharmacodynamics of lignocaine and MEGX in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259923

The influence of heart failure, liver disease, and renal failure on the disposition of lidocaine in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259923

Rapid prediction of individual dosage requirements for lignocaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259923

Computer-assisted individualized lidocaine dosage: clinical evaluation and comparison with physician performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259923

Pharmacokinetics of tocainide in patients with renal dysfunction and during haemodialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259923

Variability of early lidocaine levels in patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259923

Acute methemoglobinemia induced by topical benzocaine and lidocaine.

21 January 2018

1 reference

12 December 2020

Pharmacology of local anesthetic agents

1 reference

12 December 2020

1 reference

12 December 2020

The interaction of mexiletine with other cardiovascular drugs

1 reference

12 December 2020

Limitations of lignocaine in control of early ventricular dysrhythmias complicating acute myocardial infarction

1 reference

12 December 2020

Effect of external cardiopulmonary resuscitation on lidocaine pharmacokinetics in dogs.

1 reference

12 December 2020

Impairment of Lidocaine Clearance in Elderly Male Subjects

1 reference

12 December 2020

Mexiletine: a new type I antiarrhythmic agent

1 reference

12 December 2020

Population pharmacokinetic parameters in patients treated with oral mexiletine

1 reference

12 December 2020

Lidocaine-propranolol interactions.

1 reference

12 December 2020

Quinidine toxicity and its treatment. An Experimental study

1 reference

12 December 2020

Tissue distribution of lidocaine after fatal accidental injection.

1 reference

12 December 2020

The convulsant potency of lidocaine and its N-dealkylated metabolites

1 reference

12 December 2020

Changes in lignocaine disposition during long-term infusion in patients with acute ventricular arrhythmias.

1 reference

12 December 2020

CNS toxicity after ingestion of topical lidocaine.

1 reference

12 December 2020

Lidocaine disposition kinetics in monkey and man. I. Prediction by a perfusion model.

1 reference

12 December 2020

Mexiletine for ventricular arrhythmias

1 reference

12 December 2020

Accidental overdose of tocainide successfully treated

1 reference

12 December 2020

Fatal intoxication by tocainide.

1 reference

12 December 2020

Tocainide kinetics after intravenous and oral administration in healthy subjects and in patients with acute myocardial infarction

1 reference

12 December 2020

Lidocaine intoxication in a newborn following local anesthesia for episiotomy

1 reference

12 December 2020

Thrombocytopenia and mexiletine

1 reference

12 December 2020

Hemodynamic and electrophysiologic interactions between antiarrhythmic drugs and beta blockers, with special reference to tocainide

1 reference

12 December 2020

Apneic and hypotensive effects of local anesthetic drugs in dogs and mice under general anesthesia.

1 reference

12 December 2020

"Doom anxiety" and delirium in lidocaine toxicity

1 reference

12 December 2020

Concentrations of lidocaine and monoethylglycylxylidide (MEGX) in lidocaine associated deaths.

1 reference

12 December 2020

The central action of lignocaine and its effect on cardiac output

1 reference

12 December 2020

Lethal/toxic injection of 20% lidocaine: a well-known complication of an unnecessary preparation?

1 reference

12 December 2020

Lidocaine plasma concentrations following administration of intraoral lidocaine solution.

1 reference

12 December 2020

Effects of histamine-2 receptor blockade on lidocaine kinetics.

1 reference

12 December 2020

Influence of the status of the patient on systemic effects of local anesthetic agents

1 reference

12 December 2020

Drug-induced convulsions. Report from Boston Collaborative Drug Surveillance Program

1 reference

12 December 2020

Effect of the duration of infusion on the disposition of lidocaine in dogs

1 reference

12 December 2020

Pharmacokinetics of oral mexiletine in patients with acute myocardial infarction

1 reference

12 December 2020

Electrical seizure activity produced by Xylocaine and Citanest

1 reference

12 December 2020

Continuous infusion of lidocaine in patients with cardiac arrhythmias. Unpredictability of plasma concentrations.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03259923

1 reference

31 August 2017

1 reference